[[1] A.F. Butt, M.N. Ahmed, M.H. Bhatti, M.A. Choudhary, K. Ayub, M.N. Tahir, and T. Mahmood, “Synthesis, structural properties, DFT studies, antimicrobial activities and DNA binding interactions of two newly synthesized organotin (IV) carboxylates”, J. Mol. Struct., Vol. 1191, Pp. 291-300, 2019.10.1016/j.molstruc.2019.04.066]Search in Google Scholar
[[2] M. Sirajuddin, S. Ali, V. McKee, N. Akhtar, S. Andleeb, and A. Wadood, “Spectroscopic characterizations, structural peculiarities, molecular docking study and evaluation of biological potential of newly designed organotin (IV) carboxylates”, J. Photochem. Photobiol. B., Vol. 197, Pp. 111-116, 2019.10.1016/j.jphotobiol.2019.111516]Search in Google Scholar
[[3] A. Munir, M. Sirajuddin, M. Zubair, A. Haider, S.A. Tirmizi, S. Ali, and I. Aziz, “Synthesis, spectroscopic characterization, and biological screening of levofloxacin based organotin (IV) derivatives”, Russ. J. Gen. Chem., Vol. 87, No. 10, Pp. 2380-2390, 2017.10.1134/S1070363217100206]Search in Google Scholar
[[4] F.F. Yan, Q. Zhu, Q.L. Li, R.F. Zhang, and C.L. Ma, “Triorganotin coordination polymers based on three dicarboxylate ligands containing flexible SS bonds: synthesis, structures and in vitro anti-tumor activity”, J. Organomet. Chem., Vol. 880, Pp. 156-162, 2019.10.1016/j.jorganchem.2018.11.003]Search in Google Scholar
[[5] I. Ahmad, A. Waseem, M. Tariq, C. Macbeth, J. Bacsa, D. Venkataraman, and S. Tabassum, “Organotin (IV) derivatives of amide-based carboxylates: Synthesis, spectroscopic characterization, single crystal studies and antimicrobial, antioxidant, cytotoxic, anti-leishmanial, hemolytic, noncancerous, anticancer activities”, Inorg. Chim. Acta, Pp. 119-133, 2020.10.1016/j.ica.2020.119433]Search in Google Scholar
[[6] S. Naz, M. Sirajuddin, I. Hussain, A. Haider, A. Nadhman, A. Gul, and S. Ali, “2-Phenylbutyric acid based organotin (IV) carboxylates; synthesis, spectroscopic characterization, antibacterial action against plant pathogens and in vitro hemolysis”, J. Mol. Struct., 1203, 127378, 2020.10.1016/j.molstruc.2019.127378]Search in Google Scholar
[[7] M. Sirajuddin, V. McKee, M. Tariq, and S. Ali, “Newly designed organotin (IV) carboxylates with peptide linkage: synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations”, Eur. J. med. Chem., Vol. 143, Pp. 1903-1918, 2018.10.1016/j.ejmech.2017.11.001]Search in Google Scholar
[[8] M. Sirajuddin, S. Ali, V. McKee, and A. Matin, “Synthesis, characterization and biological screenings of 5-coordinated Organotin (IV) complexes based on carboxylate ligand”, J. Mol. Struct., 127683, 2020.10.1016/j.molstruc.2020.127683]Search in Google Scholar
[[9] R. Guan, Z. Zhou, M. Zhang, H. Liu, W. Du, X. Tian, and Y. Tian, “Organotin (IV) carboxylate complexes containing polyether oxygen chains with two-photon absorption in the near infrared region and their anticancer activity”, Dyes Pigments, Vol. 158, Pp. 428-437, 2018.10.1016/j.dyepig.2018.05.072]Search in Google Scholar
[[10] C.N. Banti, S.K. Hadjikakou, T. Sismanoglu, and N. Hadjiliadis, “Anti-proliferative and antitumor activity of organotin (IV) compounds. An overview of the last decade and future perspectives”, J. Inorg. Biochem., Vol. 194, Pp. 114-152, 2019.10.1016/j.jinorgbio.2019.02.003]Search in Google Scholar
[[11] A.M. Sakho, D. Du, W. Li, S. Liu, D. Zhu, and L. Xu, “Synthesis, crystal structures, and antitumor activity of three new organotin carboxylates”, Heteroatom Chem., Vol. 21, No. 5, Pp. 304-313, 2010.10.1002/hc.20614]Search in Google Scholar
[[12] J.O. Adeyemi, D.C. Onwudiwe, A.C. Ekennia, S.N. Okafor, and E.C. Hosten, “Organotin (IV) N-butyl-N-phenyldithiocarbamate complexes: Synthesis, characterization, biological evaluation and molecular docking studies”, J. Mol. Struct., Vol. 1192, Pp. 15-26, 2019.10.1016/j.molstruc.2019.04.097]Search in Google Scholar
[[13] K.M. Fock, T.L. Ang, L.C. Bee, and E.J.D. Lee, “Proton pump inhibitors”, Clin. Pharmacokinet, Vol. 47, No. 1, Pp. 1-6, 2008.10.2165/00003088-200847010-00001]Search in Google Scholar
[[14] L.S. Welage, and R.R. Berardi, “Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases”, J. Am. Pharm. Assoc., Vol. 40, No.1, Pp. 52-62, 2000.10.1016/S1086-5802(16)31036-1]Search in Google Scholar
[[15] F. Salama, N. El-Abasawy, S.A. Razeq, M.M.F. Ismail, and M.M. Fouad, “Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates”, J. Pharmaceu. Biomed. Anal., Vol. 33, No. 3, Pp. 411-421, 2003.10.1016/S0731-7085(03)00233-4]Search in Google Scholar
[[16] C. Vidaillac, J. Guillon, C. Arpin, I. Forfar-Bares, B.B. Ba, J. Grellet, and C. Quentin, “Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus”, Antimicrob. Agents chemother. Vol. 51, No. 3, Pp. 831-838, 2007.10.1128/AAC.01306-05180315617101679]Search in Google Scholar
[[17] M. Tariq, M. Sirajuddin, S. Ali, N. Khalid, and N.A. Shah, “Biological evaluations and spectroscopic characterizations of 3-(4-ethoxyphenyl)-2-methylacrylate based organotin (IV) carboxylates derivatives”, Russ. J. Gen. Chem., Vol. 87, No. 11, Pp. 2690-2698, 2017.10.1134/S1070363217110263]Search in Google Scholar
[[18] M. Tariq, N. Muhammad, S. Ali, J.H. Shirazi, M.N. Tahir, and N. Khalid, “Synthesis, spectroscopic, X-ray crystal structure, biological and DNA interaction studies of organotin (IV) complexes of 2-(4-ethoxybenzylidene) butanoic acid. Spectrochim”, Acta A:, Vol. 122, Pp. 356-364, 2014.10.1016/j.saa.2013.11.06524322756]Search in Google Scholar
[[19] M. Iqbal, S. Ali, A. Haider, and N. Khalid, “Therapeutic properties of organotin complexes with reference to their structural and environmental features”, Rev. Inorg. Chem., Vol. 37, No. 2, Pp. 51-70, 2017.10.1515/revic-2016-0005]Search in Google Scholar
[[20] R. Kumar, A. Rani, S.P. Singh, K.M. Kumari, and S.S. Srivastava, “A long term study on chemical composition of rainwater at Dayalbagh, a suburban site of semiarid region”, J. Atmos. Chem., Vol. 41, No. 3, Pp. 265-279, 2002.10.1023/A:1014955715633]Search in Google Scholar
[[21] N. Rani, A. Sharma, and R. Singh, “Imidazoles as promising scaffolds for antibacterial activity: a review”, Mini Rev. Med. Chem., Vol. 13, No. 12, Pp. 1812-1835, 2013.10.2174/13895575113136660091]Search in Google Scholar
[[22] L. Zhang, X.M. Peng, G.L. Damu, R.X. Geng, and C.H. Zhou, “Comprehensive review in current developments of imidazole-based medicinal chemistry”, Med. Res. Rev., Vol. 34, No. 2, Pp. 340-437, 2014.10.1002/med.2129023740514]Search in Google Scholar
[[23] W.L. Armarego, and C.L. Chai, “Purification of laboratory chemicals”, third ed., Pergamon Press, Berlin, 2013.10.1016/B978-0-12-382161-4.00004-2]Search in Google Scholar
[[24] M.I. Choudhary, and W.J. Thomsen, “Bioassay techniques for drug development”, CRC Press. Harwood Academic Publishers, Amsterdam, The Netherlands, 2001.]Search in Google Scholar
[[25] M. Tariq, N. Muhammad, M. Sirajuddin, S. Ali, N.A. Shah, N. Khalid, and M.R. Khan, “Synthesis, spectroscopic characterization, X-ray structures, biological screenings, DNA interaction study and catalytic activity of organotin (IV) 3-(4-flourophenyl)-2-methylacrylic acid derivatives”, J. Organomet. Chem., Vol. 723, Pp. 79-89, 2013.10.1016/j.jorganchem.2012.09.011]Search in Google Scholar
[[26] S. Nazir, J. Anwar, M.A. Munawar, J.I. Qazi, S.P. Best, M. Cheah, and M. Yaseen, “Metal complexation induces antibiotic activity in S-ethyl-l-cysteine sulfoxide”, Inorg. Chim. Acta, Vol. 478, Pp. 166-175, 2018.10.1016/j.ica.2018.04.002]Search in Google Scholar
[[27] M. Calligaris, “Structure and bonding in metal sulfoxide complexes: an update”, Coord. Chem. Rev., Vol. 248, No. 3-4, Pp. 351-375, 2004.10.1016/j.ccr.2004.02.005]Search in Google Scholar